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Abstract 
Background: High resistance (the ability of the host to reduce pathogen load) and tolerance (the ability to maintain 
high performance at a given pathogen load) are two desirable host traits for producing animals that are resilient to 
infections. For Porcine Reproductive and Respiratory Syndrome (PRRS), one of the most devastating swine diseases 
worldwide, studies have identified substantial genetic variation in resistance of pigs, but evidence for genetic varia‑
tion in tolerance has so far been inconclusive. Resistance and tolerance are usually considered as static traits. In this 
study, we used longitudinal viremia measurements of PRRS virus infected pigs to define discrete stages of infection 
based on viremia profile characteristics. These were used to investigate host genetic effects on viral load (VL) and 
growth at different stages of infection, to quantify genetic variation in tolerance at these stages and throughout the 
entire 42‑day observation period, and to assess whether the single nucleotide polymorphism (SNP) WUR10000125 
(WUR) with known large effects on resistance confers significant differences in tolerance.
Results: Genetic correlations between resistance and growth changed considerably over time. Individuals that 
expressed high genetic resistance early in infection tended to grow slower during that time‑period, but were more 
likely to experience lower VL and recovery in growth by the later stage. The WUR genotype was most strongly associ‑
ated with VL at early‑ to mid‑stages of infection, and with growth at mid‑ to late‑stages of infection. Both, single‑stage 
and repeated measurements random regression models identified significant genetic variation in tolerance. The WUR 
SNP was significantly associated only with the overall tolerance slope fitted through all stages of infection, with the 
genetically more resistant AB pigs for the WUR SNP being also more tolerant to PRRS.
Conclusions: The results suggest that genetic selection for improved tolerance of pigs to PRRS is possible in prin‑
ciple, but may be feasible only with genomic selection, requiring intense recording schemes that involve repeated 
measurements to reliably estimate genetic effects. In the absence of such records, consideration of the WUR geno‑
type in current selection schemes appears to be a promising strategy to improve simultaneously resistance and toler‑
ance of growing pigs to PRRS.
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Background
Infectious diseases pose a considerable problem for live-
stock production. Where conventional control strate-
gies, such as culling or vaccination, have limited success 
in controlling or eliminating an infectious agent, genetic 
selection for improved host response to infection chal-
lenge may be an attractive solution [1].
In livestock production, disease resilience, defined 
as the ability of a host to maintain high production lev-
els when challenged with infectious pathogens [2], has 
become a desirable breeding goal trait [3, 4]. Disease 
resilience comprises two alternative defence mechanisms 
under potential host genetic control: resistance, which is 
the ability of the host to inhibit or reduce pathogen rep-
lication [5–8]; and tolerance, which is the ability of the 
host to limit the impact of the infection on host perfor-
mance, without necessarily affecting pathogen burden 
[9–12]. Hence, both tolerance and resilience measure 
how performance is affected by infectious challenge, 
but resilience does not take differences in within-host–
pathogen burden (i.e. resistance) into account, whereas 
tolerance measures performance at given within-host–
pathogen burden. Both resilience components, i.e. resist-
ance and tolerance may harbour substantial genetic 
variation and covariation, and are thought to have differ-
ent impacts on disease epidemiology and pathogen evo-
lution [13, 14]. Furthermore, a recent theoretical study 
has shown that inclusion of both resistance and tolerance 
in the selection objective can lead to higher genetic gain 
in performance under pathogen challenge than selec-
tion on resilience [15]. Thus, identifying and quantifying 
genetic variation (and co-variation) in both these traits, 
host resistance and tolerance, is crucial for devising effec-
tive breeding programmes that maintain high health and 
production levels in the face of infectious challenges. 
Numerous disease challenge experiments have provided 
ample evidence for considerable genetic variance in host 
resistance [16]. In contrast, estimates for genetic variance 
in tolerance of farm animals to infections are still sparse, 
in part because tolerance is defined as the slope of reac-
tion-norms of performance against within-host–patho-
gen burden [17], for which reliable variance component 
estimates are difficult to obtain [18].
Genetic improvement of host resistance and toler-
ance has been considered as a viable disease control 
strategy for Porcine Reproductive and Respiratory Syn-
drome (PRRS) [13]. PRRS is an endemic viral disease that 
causes respiratory problems and considerable reduction 
in piglet growth rate and sow reproductive performance 
[19–21], and has led to severe economic losses to the 
swine industry in countries worldwide [22, 23]. Large-
scale PRRS virus (PRRSV) challenge studies carried out 
by the PRRS Host Genetics Consortium (PHGC) have 
demonstrated considerable genetic variation in resistance 
of growing piglets to PRRSV infection based on viral load 
(VL) (within-host VL, defined as cumulative log viremia 
until 21 days post-infection), as well as in growth under 
infection, regardless of VL (i.e. resilience) [24–26]. Fur-
thermore, using the same datasets, a quantitative trait 
locus (QTL) was identified on chromosome 4, where the 
single nucleotide polymorphism (SNP) WUR10000125 
(WUR) explained 13.2 and 9.1% of the genetic variance 
for VL and growth, respectively [24–26]. Pigs that were 
heterozygous AB for the WUR locus had on average 
4.5% lower VL and grew on average 2 kg more over the 
42-day infection period than individuals with the unfa-
vourable AA genotype. Our previous study of the same 
PHGC data found inconclusive evidence for genetic vari-
ation in tolerance of pigs to PRRS, which was attributed 
to limited statistical power to disentangle genetic effects 
related to the overall growth response under infection, 
regardless of VL and those related to tolerance [10]. This 
previous study, which was based on VL and growth as 
single cumulative measures for each individual over time 
periods of 21 or 42 days, concluded that more measure-
ments, in particularly a wider spread of individual VL 
measurements for fitting regression curves (e.g. includ-
ing zero VL), would potentially resolve this confounding 
and may permit accurate estimation of genetic variance 
in tolerance [10].
The hypothesis of the current research was that signifi-
cant genetic variance in tolerance of pigs to PRRS exists 
and can be detected by partitioning the infection period 
into distinct stages of infection. This harnesses available 
longitudinal information of pigs’ responses to infection 
and builds on several independent studies, which indi-
cated that tolerance changes over the time-course of 
infection [11, 12, 27, 28]. Hence, variance estimates for 
tolerance may also change over time. The specific aims of 
this research were to estimate genetic variation in toler-
ance at different stages following experimental infection 
with PRRSV, defined by viremia curve characteristics, 
and throughout the whole 42-day observation period, by 
using the PHGC data from the different infection stages 
in repeated measures models. Furthermore, this study 
investigated whether the previously identified WUR 
SNP, which is associated with resistance and growth 
under infection, was also associated with tolerance, and 
whether the strength of the association of the WUR SNP 
with resistance and growth changed during the course of 
the infection.
Methods
Infection experiment and data
The PRRS Host Genetics Consortium (PHGC) data-
set used in this study was the same as that of a previous 
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study that provided inconclusive evidence for genetic 
variation in tolerance [10]. Briefly, data from 1569 com-
mercial crossbred growing pigs supplied by various 
breeding companies were collected from nine PRRSV 
challenge trials following an identical infection protocol 
[29]. The animal composition in each of these trials is in 
Additional file 1: Table S1. At weaning age (mean age was 
26 days, and ages ranged from 17 to 32 days), around 200 
piglets in each trial were transferred from farms (free of 
PRRSV, Mycoplasma hyopneumoniae, and swine influ-
enza virus) to a research facility at Kansas State Univer-
sity. Pigs were randomly assigned to pens of between 10 
and 15 individuals. After a 7-day acclimation period, pigs 
were infected both intranasally and intramuscularly with 
 105 (TCID50) of NVSL-97-7985, a highly virulent PRRSV 
type-2 isolate [30]. Data were collected for body weight 
(BW) weekly and from blood samples at 0, 4, 7, 11, 14, 
21, 28, 35 and 42  days-post-infection (dpi). At 42 dpi, 
pigs were euthanized and ear notches were collected for 
genotyping. Due to facility availability, trials 7 and 8 were 
terminated at 35 dpi. As described in Boddicker et  al. 
[24], serum virus load, measured by a semi-quantitative 
TaqMan PCR assay for PRRSV RNA, provided repeated 
measures for  log10-transformed qPCR viremia.
Across all trials, 198 pigs died before 42 dpi. The pri-
mary cause of mortality was attributed to PRRS, except 
for trial 6, which had 46% higher mortality than the other 
trials due to secondary bacterial infections [31]. Nev-
ertheless, data from these pigs prior to death were also 
included in the analyses [6, 11, 24, 31].
Pedigree and genomic information from Illumina’s Por-
cine SNP60 Beadchip v.1 [32] was known for all pigs. The 
pedigree-based numerator relationship matrix ( A ) was 
constructed in ASReml 3.0 [33]. Each pig was assigned 
to one of three WUR genotypes, using the Illumina 
A/B genotype reference system (AA = 689, AB = 286 
and BB = 36, where allele B was known to confer higher 
growth and lower VL).
As in the previous tolerance study [10], only offspring 
from sires with more than 10 progeny with phenotypes 
were considered to reduce the risk of bias in tolerance 
estimates [17]. As such, the number of animals included 
was 1001 from 49 sires. In contrast to our previous study 
[10], 214 pigs that had experienced a rebound in viremia 
(i.e. a second period of increased serum virus load), as 
identified by curve fitting [34], were omitted from the 
analyses. Hence, all pigs considered in this study expe-
rienced a gradual viremia decline after peak viremia had 
been reached. This allowed the 42-day infection period to 
be partitioned into three distinct stages based on com-
mon viremia curve characteristics, as described in the 
next section.
Defining stages of infection
In contrast to most previous genetic studies of these 
PHGC data, which defined resistance and tolerance 
over 0 to 21 or 0 to 42 dpi periods [6, 10, 24, 31], in this 
study the experimental observation period was parti-
tioned into three stages, i.e. early-, mid- and late-stage 
of infection. Stages of infection were defined individually 
based on viremia profile characteristics obtained by fit-
ting the mathematical Woods function described below 
to the repeated viremia measures of each individual pig, 
as illustrated in Fig.  1 [26, 34]. More specifically, the 
Wood’s function, which had previously been shown to 
be a good fit for the viremia data of an individual pig i 
Fig. 1 Illustration of an individual viremia profile used to define stages of infection. Black dots represent log‑transformed viremia measures, and the 
blue line represents the fitted Woods function over the time‑course of infection (up to 42 dpi) for one individual. Early‑stage of infection is defined 
from initial infection (0 dpi) to time when peak viremia ( Vpeak ) is reached ( Tpeak in this example, approximately 6 dpi); mid‑stage of infection is 
defined from Tpeak to Tmax ( Tmax in this example, approximately 19 dpi); and late‑stage of infection, defined from Tmax to end of experiment (42 dpi, 
or 35 dpi for trials 7 and 8)
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that did not experience viremia rebound [34], is given by 
Vi(t) = aitbi e−cit , where Vi(t) is the  log10 scaled serum 
viremia of pig i at t dpi; ai is a scaler quantity which 
defines the overall height of the curve; bi governs the rate 
of increase to peak viremia, and parameter ci is an indi-
cator of the rate of decline after peak viremia. Using the 
analytical expression for (t) , two critical time points can 
be derived by differentiation: Tpeaki = bˆicˆi  , the time when viremia reaches its maximum value and Tmaxi = bˆi+
√
bˆi
cˆi
 , 
the time post-peak viremia when the rate of viremia 
decline reaches its maximum (i.e. the inflection point of 
the Woods function). These critical time points ( Tpeak 
and Tmax , respectively) were used to define the lower and 
upper boundaries of each stage of infection in this study. 
Thus, stages of infection were defined for each individual 
from time of initial infection (0 days post-infection (dpi)) 
to Tpeaki (early); from Tpeaki to Tmaxi (mid), and from Tmaxi 
to the end of the observed infection period, which was 
at 35 dpi for trials 7 and 8, and 42 dpi for all other tri-
als (late). This way, the early-stage corresponds to the 
phase of rapid viremia increase towards individual peak 
viremia, the mid-stage corresponds to the initial phase of 
rapid post-peak viremia decline, and the late-stage cor-
responds to the phase where viremia continues to decline 
at a decreasing rate.
Since the Woods function was fitted to each individual 
separately [34], estimates for the parameters Tpeak and 
Tmax were obtained for each individual. Table  1 shows 
the variation in the corresponding time-periods for each 
stage of infection. Average duration of each stage of 
infection was 6.90, 9.19 and 14.26  days for early-, mid- 
and late-stages of infection, respectively, correspond-
ing to average Tpeak and Tmax of 6.90 and 16.16  days, 
respectively.
In line with previous studies, resistance during a particu-
lar stage of infection was then quantified as the inverse of 
the cumulative log-transformed VL over the corresponding 
time-period [9, 10, 18, 26]. This was calculated as the area 
under the curve of the log-transformed viremia estimates 
throughout the observation period, obtained by numerical 
integration of the Woods function over the corresponding 
time-periods, yielding estimates for VL at early-, mid- and 
late-stages of infection.
To calculate the corresponding ADG for each stage of 
infection, a linear spline curve was fitted through weekly 
body weights (BW) for each individual using the smooth.
spline function in R. BW was interpolated at time of 
peak viremia ( Tpeak ) and time of maximal viremia decay 
( Tmax ) using the predict function in R. From this, ADG at 
early-, mid- and late-stages of infection were calculated 
by dividing the difference in smoothed body weight at the 
start and end of the stage in consideration by the corre-
sponding duration.
Statistical analyses
All statistical analyses were carried out using ASReml 3.0 
[33], with genetic relatedness described by the pedigree 
relationship matrix for consistency with our previous tol-
erance analysis of the same dataset [10, 33]. Replacing the 
pedigree relationship matrix with a genomic relationship 
matrix (which can capture differences between siblings 
due to Mendelian sampling) had only negligible impact 
on the variance estimates and on the goodness of fit sta-
tistics (results not shown).
Estimating the genetic correlation between ADG and VL 
within and between stages of infection
The first step in the analysis of the variation in resistance 
and tolerance to infection was to estimate heritabilities 
and correlations between VL and growth at each stage of 
infection using a conventional bi-variate animal model 
for VL and ADG for all individual stages of infection:
where yi and yj are vectors of phenotypes for ADG ( yi ), 
and VL ( yj ), respectively, at the stages i and j of infection 
(e.g. ADG at stage i , { i = early, mid, late} and VL at stage 
j , { j = early, mid, late}); b1 and b2 are the vectors of the 
trait means and fixed effects for the interaction of experi-
mental trial and parity of the dam when offspring were 
born (trial-by-parity), sex of the offspring, BW and age at 
the start of experimental infection included as additional 
fixed covariates to account for body weight at the initial 
infection and variation in age at the  start of infection, 
respectively. Note that no breed effect was included in 
the model since trial and breed effects were fully 
(1)
[
yi
yj
]
=
[
X1 0
0 X2
][
b1
b2
]
+
[
Z1 0
0 Z2
][
a1
a2
]
+
[
U1 0
0 U2
][
p1
p2
]
+
[
M1 0
0 M2
][
l1
l2
]
+
[
e1
e2
]
,
Table 1 Descriptive statistics of duration (days) for each 
stage of infection
Early-stage is defined as initial infection (0 dpi) to Tpeak ; mid-stage is defined 
as Tpeak to Tmax , and late-stage of infection is defined from Tmax to end of 
the observation period (35 dpi for trials 7 an 8 and 42 dpi for all other trials). 
Descriptive statistics of Tpeak and Tmax are also shown. All measures are in days
Stage 
of infection
Mean Standard 
deviation
Minimum Maximum
Early 6.90 1.32 3.01 10.60
Mid 9.19 2.11 4.04 14.87
Late 14.26 0.60 13.53 14.92
Tpeak 6.90 1.32 3.01 10.60
Tmax 16.16 2.38 10.01 26.97
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confounded in this experiment; a1 , and a2 are the vectors 
of additive genetic effects for each trait, with 
Var
[
a1
a2
]
= G⊗ A , where G is the genetic variance–
covariance matrix and A the pedigree relationship 
matrix; p1 and p2 are the vectors of pen effects nested 
within a trial for each trait, with Var
[
p1
p2
]
= I⊗ K , 
where I is the identity matrix and K is the corresponding 
variance–covariance matrix of pen effects for the differ-
ent traits; l1 and l2 are the vectors of litter effects for each 
trait, with Var
[
l1
l2
]
= I⊗ L , with the corresponding var-
iance–covariance matrix L ; e1 , and e2 are the vectors of 
error terms for each trait, with Var
[
e1
e2
]
= I⊗ R , where 
R is the variance–covariance matrix for the residual 
effects for each trait; and X1 and X2 , Z1 and Z2 , U1 and 
U2 , and M1 and M2 are the incidence matrices for the 
fixed, animal, pen and litter effects, respectively. In addi-
tion to the bivariate animal model, corresponding univar-
iate models were also used to check the robustness of 
variance components. Since heritability estimates dif-
fered between models, heritability estimates from the 
univariate models are presented.
Estimation of the genetic variance in tolerance at each 
stage of infection
To estimate genetic variance in tolerance, a random 
regression reaction-norm model was applied to the data. 
Information on performance in absence of infection was 
unavailable. To account for this, the origin of the reac-
tion-norms (intercept) was centred at the mean VL for 
each stage of infection across all animals, referred to as 
‘level.’ As described in a previous study [10], the linear 
random regression sire model (RRM) for ADG on cen-
tred values of VL, which will be referred to as the level-
slope model, was used to identify genetic variance in 
tolerance at each stage of infection, where ADG at early-, 
mid- and late-stages of infection were regressed either on 
VL at the corresponding or previous stages of infection 
(for example ADG at late-stage of infection regressed on 
VL at mid-stage of infection):
where y is the vector of ADG at early-, mid- or late-stages 
of infection; b is the vector of fixed effects described in 
model (1), where level (overall mean at centred VL) is 
fixed; and bs is the population average tolerance slope 
(fixed VL); ai and as are the sire effects on level (intercept 
at centred VL) and on tolerance slope, respectively, 
(2)
y = Xb+ XVLbs + Zai + ZVLas +Up+Ml + e,
assumed to follow a multi-variate normal distribution 
with a mean of zero and Var
[
ai
as
]
= 14G⊗ A , with 
G =
[
σ
2
ai
σaias
σaias σ
2
as
]
 where σ2ai and σ
2
as
 are the variance of ai , 
and as , respectively, σaias is the covariance between sire 
effects for level and slope; the random pen and litter 
effects p and l were fitted as described in model (1); e is 
the vector of error terms, with Var(e) = I⊗ R , where R is 
the variance–covariance matrix, assumed to be indepen-
dently normally distributed. Heterogeneous diagonal 
residual structures were also tested, but this was found to 
result in almost the same residual variance estimates and 
did not improve the model fit, as indicated by Akaike’s 
information criterion (AIC). XVL and ZVL are the inci-
dence matrices for population average tolerance slope 
and those associated with each sire, respectively, consist-
ing of the VL of each pig at the chosen stage of infection; 
X is the incidence matrix for the fixed effects, Z is the 
incidence matrix for the random sire effect on level; and 
U and M are the incidence matrices for pen and litter 
effects, respectively.
To test the significance of sire effects on level and slope, 
the model fit of the level-slope model was compared with 
that of nested models without any additive genetic effects 
(null model), and with only sire effects for level (level-
model). Significance of each random effect was assessed 
using the likelihood ratio test (LRT) [35], with the LRT 
test statistics assumed to follow a χ2 distribution with a 
mixture of 0 and 1 degrees of freedom for the inclusion 
of sire effects only (e.g. null to level model, including 
sire effect) and a mixture of 1 and 2 degrees of freedom 
for the addition of sire slope effects and covariance (for 
example, from level to level-slope model) [36, 37].
Estimation of the genetic variance in tolerance 
across stages of infection using a repeated measurement 
model
Next, to identify and estimate the genetic variance in 
tolerance across all stages of infection, ADG at the three 
stages of infection was considered as a repeated measure 
of the same trait and analyzed using the following univar-
iate random regression sire model (level-slope repeated 
measures model):
where y is the vector of repeated measures of ADG at 
early-, mid- and late-stages of infection (i.e. dimension 
3 × number pigs considered in the study) and the inci-
dence matrices XVL , ZVL and WVL contain VL measures 
(3)
y = Xb+ XVLbs + Zai + ZVLas +Wci
+WVLcs +Up+Ml + e,
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of individual pigs of the same stage of infection as the 
ADG-measurement in y . The same fixed and genetic and 
additional random effects were fitted as described in 
model (2), with the addition of ci and cs , denoting the 
vectors of permanent environmental effects for level and 
slope, respectively, for each individual, where 
Var
[
ci
cs
]
= I⊗ C , with C =
[
σ
2
ci
σcics
σ
2
cics
σ
2
cs
]
 , where σ2ci and 
σ
2
cs
 are the variance of ci , and cs , respectively, and σcics is 
the covariance between permanent environmental effects 
for level (overall mean at centred VL) and slope; with 
respective incidence matrices W and WVL. As described 
above, evidence for significant genetic variation in toler-
ance was obtained by comparing the model fit with that 
of the corresponding null and level repeated measure 
models using the LRT.
Association of the WUR genotype with growth, resistance 
and tolerance
Associations of the WUR genotype with growth and 
resistance at each stage of infection were estimated by 
including the WUR genotype (coded as − 1, 0, 1 for AA, 
AB and BB, respectively) as fixed covariate in model (1). 
Similarly, associations of the WUR genotype with level 
and tolerance at each stage or across all stages of infec-
tion was assessed by including WUR genotype and WUR 
genotype-by-VL as additional fixed covariates in models 
(2) and (3). Thus, a statistically significant WUR geno-
type-by-VL interaction indicates genotypic differences 
in tolerance. Significance of the associations of the WUR 
genotype with traits was assessed based on Wald test sta-
tistics, where p < 0.05 was the significance threshold, as 
well as the LRT. The additive variance explained by the 
SNP was calculated as 2pqα2 , where p and q refer to the 
frequencies of A and B alleles in the population, respec-
tively, and the allele substitution effect α for the trait in 
consideration was obtained from the corresponding 
models above. In this dataset, p and q were equal to 0.82 
and 0.18, respectively, and the corresponding observed 
proportion of pigs with AA, AB and BB genotypes were 
0.68, 0.28 and 0.04.
Results
Genetic parameters and relationship between ADG and VL 
across stages of infection
ADG for individual stages of infection ranged from − 110 
to 800 g/day, with the minimum (− 110 g/day) and maxi-
mum ADG (800  g/day) observed at the early- and late-
stages of infection, respectively (Table  2). Mean ADG 
increased with stage of infection from 250 to 430 g/day 
at early- and late-stages of infection, respectively, indicat-
ing that individuals were, generally, able to grow faster at 
later stages of infection. Mean VL increased from 37.1 to 
67.6 units from the early- to the late-stage of infection. 
This apparent increase does not reflect a higher virus 
load at a particular time point during the correspond-
ing stages, but is primarily due to the longer time-period 
associated with the late-stage of infection (on average 
14.3 days compared to 6.9 and 9.2 days for the early- and 
mid-stages of infection, respectively). The coefficient 
of variation for growth rate was largest at the mid-stage 
of infection, whereas for VL it was approximately stable 
across stages (Table 2).
Both ADG and VL were found to be moderately herita-
ble for each stage of infection (Table 3). Heritability of VL 
was highest at the mid-stage (between peak viremia and 
max viremia clearance (0.31)). Conversely, the heritabil-
ity of ADG gradually decreased over subsequent stages of 
infection (from 0.28 to 0.16).
Estimates of genetic correlations between stages of 
infection were generally high and positive for ADG 
(in the range from 0.70 to 0.84), while phenotypic cor-
relations were also positive but weaker (Table  3). The 
bivariate models estimated genetic correlations for VL 
to be strong between consecutive stages of infection 
(0.75  to  0.82), but close to zero between the early- and 
late-stages (0.01), indicating that individuals genetically 
predisposed to experience lower VL early in infection 
did not necessarily have lower VL at the late stage. Phe-
notypic correlations for VL were moderate to strong 
between consecutive stages, but weak and negative 
between the early- and late-stages. Estimates of genetic 
correlations between ADG and VL varied in magnitude 
and sign depending on stage of infection, and had high 
standard errors. At the early- and mid-stages of infection, 
genetic correlations between ADG and VL were weakly 
to moderately positive (0.06 and 0.23 for early- and mid-
stages, respectively). The strongest genetic correlation 
between VL and ADG (0.73 ± 0.24)) was observed for 
ADG at mid-stage of infection with VL at early-stage of 
infection, implying that individuals with higher genetic 
resistance for the early-stage of infection tended to 
Table 2 Descriptive statistics of growth (ADG) and viral 
load (VL) at different stages of infection
ADG is measured in g/day and VL in AUC(log10 RT-PCR). Stages of infection are 
early-, mid-and late-stages
Trait Mean Phenotypic 
Standard 
deviation
Minimum Maximum
ADGearly 250 10 − 110 640
ADGmid 290 10 − 90 680
ADGlate 430 20 0 800
VLearly 37.1 6.4 16.4 57.2
VLmid 58.4 9.5 35.6 87.1
VLlate 67.6 10.7 39.1 99.3
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experience a temporary reduction in growth after peak 
viremia. However, by the late-stage of infection, the 
genetic correlation between ADG and VL became strong 
and negative (− 0.74 ± 0.21), indicating that individuals 
whose genetic resistance led to lower VL at the clear-
ance stage of infection tended to grow faster during that 
period. Phenotypic correlations between ADG and VL 
were typically weak across all stages of infection.
Evidence for genetic variation in tolerance at each stage 
of infection
The null reaction-norm model [i.e. model (2)], which 
included VL as a fixed covariate but no genetic effects, 
identified a statistically significant linear association 
between growth and VL when late-stage ADG was 
regressed on mid-stage VL (p = 0.02) and when late-stage 
ADG was regressed on late-stage VL (p < 0.0001). No sig-
nificant association was found between early-stage VL 
and growth at any stage of infection. As such, only mod-
els that included covariates for mid- and late-stage VL, 
respectively, are considered from hereon.
In the null models, population averages for tolerance 
(slope) were negative, but generally very flat (close to 0): for 
mid- and late-stage ADG on mid-stage VL, growth rate only 
decreased on average by − 1.4 (± 0.47) and − 2.4 (± 0.5) g/
day per unit increase in VL, respectively; for late-stage ADG 
on late-stage VL, the decrease in growth rate was − 1.9 
(± 0.4) g/day per unit VL increase. The log-likelihood of the 
model significantly increased when genetic effects (random 
sire effects) were included in the model (level-only model) 
for all stages of infection (p < 0.0001), indicating significant 
genetic variance in growth rate of pigs infected with PRRSV. 
Indeed, heritability estimates in the level-only reaction 
norm models (not shown) were similar to the correspond-
ing univariate models. Models that included sire effects 
for both level and tolerance slope and a genetic covariance 
between them, also yielded a significantly better fit than 
the null model for all stages of infection (p < 0.0001). How-
ever, a statistically significant improvement of model fit of 
the level-slope model over the level model (i.e. evidence for 
significant genetic variation in tolerance) was only observed 
when late-stage ADG was regressed on mid-stage VL 
(p < 0.05) (Table 4, italic figures). 
Estimates of genetic variance for level were relatively 
stable across stages of infection for both the level-only 
model and the level-slope model (Table  4). However, 
estimates of genetic variance for tolerance slope differed 
greatly between stages of infection, by up to four orders 
of magnitude (Table 4). As expected, genetic variance for 
slope was largest when late-stage ADG was regressed on 
mid-stage VL 16.4(± 10.2). The corresponding genetic 
covariance between level and tolerance slope was not sig-
nificantly different from zero.
Table 3 Genetic components of growth (ADG) and viral load (VL) at different stages of infection
Estimates of heritability of growth (ADG) and viral load (VL) are shown at early-, mid- and late-stages of infection (on the diagonal), and of genetic and phenotypic 
correlations between the traits (lower and upper off-diagonals, respectively). Phenotypic variance was calculated by summing animal, litter and pen within-trial 
variance components. Heritability was calculated by dividing the animal variance component by the phenotypic variance. Standard errors are in parentheses. Variance 
component estimates for the non-genetic random effects (from the corresponding univariate models) are in Additional file 1: Table S2
Trait ADGearly ADGmid ADGlate VLearly VLmid VLlate
ADGearly 0.28 (0.07) 0.35 (0.03) 0.23 (0.03) 0.03 (0.03) − 0.06 (0.03) − 0.10 (0.03)
ADGmid 0.70 (0.14) 0.22 (0.06) 0.36 (0.03) 0.03 (0.03) − 0.08 (0.03) − 0.13 (0.03)
ADGlate 0.77 (0.20) 0.84 (0.15) 0.16 (0.08) − 0.05 (0.03) − 0.20 (0.03) − 0.19 (0.03)
VLearly 0.06 (0.23) 0.73 (0.24) − 0.02 (0.27) 0.17 (0.10) 0.49 (0.03) − 0.28 (0.03)
VLmid − 0.09 (0.18) 0.23 (0.20) − 0.44 (0.20) 0.82 (0.08) 0.31 (0.12) 0.52 (0.02)
VLlate − 0.41 (0.23) − 0.36 (0.22) − 0.74 (0.21) 0.09 (0.26) 0.75 (0.15) 0.21 (0.09)
Table 4 Estimates of genetic variance components for ADG (g/d) regressed on VL
ADG at mid- and late-stage of infection is regressed on VL at mid- and late-stage of infection. The last column denotes the p-value of the LRT used to test whether the 
level-slope model significantly improves the model fit over the level model. For definition of stages of infection, see text. Standard errors are in brackets. Estimates 
under 1E−07 have been reported as close to 0 (~ 0)
VL ADG Level-only model Level-slope model Model fit
Level Residual Level Covariance Slope Residual P value
Mid Mid 3.47 (1.56) 11.10 (0.61) 3.39 (1.56) ~0 (~ 0) 3.40E−03 (6.24E−03) 11.00 (0.62) 0.74
Late 2.33 (1.24) 11.9 (0.67) 2.52 (1.30) − 6.90E−02 (9.61E−02) 1.64E−02 (1.02E−02) 11.60 (0.67) 0.02
Late Late 1.96 (1.15) 12.00 (0.68) 1.97 (1.15) ~0 (~ 0) ~0 (~ 0) 12.00 (0.68) 1.00
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Genetic variation for tolerance across all stages 
of infection: repeated measure model
The average tolerance slope estimated by the repeated 
measures null-model was − 0.46 (± 0.28) g/day per unit 
VL decrease and not significantly different from zero 
(p = 0.35). BW at the start of infection ranged from 3.72 
to 13.43 kg, with an average of 7.38 kg. A weak but sig-
nificant association of BW at the start of infection with 
growth under infection was found (p < 0.0001), with a 
positive regression coefficient of 19.0 (± 2.83) g/day per 
kg difference in BW. In other words, pigs that were 1 kg 
heavier at the beginning of the challenge experiment 
tended to grow on average 19 g/d faster during the 42-day 
infection period. The log-likelihood of the repeated 
measures model improved significantly when genetic 
effects for level (i.e. random sire effects) were included 
in the model (level model) (p < 0.0001) (Table 5). Further-
more, a statistically significant increase in the log-like-
lihood over the level model was observed when genetic 
effects for level, slope and a covariance between the latter 
were included (p < 0.0001), indicating significant genetic 
variation in tolerance across all stages of infection.
Association of the WUR genotype with tolerance 
at individual and across stages of infection
The WUR genotype was associated with VL at each indi-
vidual stage of infection (p < 0.0001), but was only sig-
nificantly associated with ADG at mid- and late-stages 
of infection (p < 0.0001). Individuals carrying the benefi-
cial B allele at the WUR SNP generally had lower VL and 
higher ADG than AA animals. The largest difference in 
ADG between genotypes was at the late-stage of infec-
tion, where AB individuals grew, on average 45  g/day 
faster than AA animals. However, the largest difference 
in VL occurred at the mid-stage of infection, where AB 
animals had on average 3.6 AUC units lower VL than AA 
animals.
The WUR genotype explained 43.3 and 12.3% of the 
genetic variance of early- and mid-stage VL, respectively, 
but only 4.4% of the genetic variance of late-stage VL. In 
contrast, it had no significant effect on early-stage ADG, 
but explained 19.4 and 19.7% of the genetic variance of 
mid- and late-stage ADG, respectively. Importantly, the 
WUR genotype had no significant effect on tolerance 
at any stage of infection as indicated by non-significant 
genotype-by-VL interactions (p = 0.80, 0.20 and 0.37 for 
early-, mid- and late-stages of infection, respectively).
Based on the repeated measures model, the WUR 
genotype was significantly associated with VL and ADG 
across all stages of infection. AB individuals grew, on 
average, 40  g/day faster than AA animals and had on 
average 3.8 AUC units lower VL. In contrast to analysis 
of the individual stages of infection, the WUR genotype 
was also significantly associated with tolerance based on 
the repeated measures model across all stages of infec-
tion (p = 0.004), where genotypic differences in tolerance 
were indicated by the significant genotype-by-VL inter-
action [9]. As with resistance, the B allele also conferred 
higher tolerance. Individuals with the AB genotype grew 
on average by 10 g/d more per unit increase in VL than 
individuals with the AA genotype.
Discussion
Summary of findings
Although numerous studies have left little doubt that 
pigs vary genetically in both resistance to, and growth 
under, PRRSV infection [6, 10, 24, 26, 31, 34], evidence 
for genetic variation in tolerance of pigs to PRRS has 
thus far been inconclusive [10, 13]. This study provides, 
for the first time, evidence for significant genetic varia-
tion in tolerance of pigs to PRRS. This was obtained by 
partitioning an individual’s infection into three distinct 
phases based on individual viremia profile characteris-
tics, instead of considering resistance and performance 
as single cumulative measures over a 21- or 42-day infec-
tion period, as was the case in previous analyses [6, 10, 
Table 5 Genetic and permanent environmental variance 
components for ADG (g/d) obtained by the repeated 
measures model
Estimates include ADG and VL measures for all three defined stages of infection 
(early, mid and late), together with the Log-Likelihood value associated with 
the different models. Variance components estimated from random regression 
models: null model, containing no genetic effect; level-only model, containing 
only the overall sire effect on growth under infection; and level-slope model, 
containing sire effects on level and slope, respectively. All other fixed effects/
covariates and random effects were identical between models. Variance 
component estimates for the other random effects (e.g. pen, litter, common 
environmental, residuals) were identical between the models and not shown. 
Standard errors are in brackets
Null repeated 
measure 
model
Level-only 
repeated 
measure model
Level-slope 
repeated 
measure model
Genetic
 Level 2.16 (0.91) 2.89 (1.16)
 Covariance 0.103 (0.054)
 Slope 0.012 (0.003)
PEV
 Level 2.01 (0.34) 2.01 (0.34) 2.89 (1.16)
 Covariance 0.03 (0.01) 0.03 (0.01) 0.103 (0.005)
 Slope 0.002 (0.001) 0.003 (0.001) 0.01 (0.003)
Other
 Pen 0.62 (0.20) 0.66 (0.20) 0.66 (0.20)
 Litter 1.21 (0.29) 0.70 (0.26) 0.70 (0.27)
 Residual 10.51 (0.39) 10.49 (0.39) 10.15 (0.38)
 Log Likelihood 4846.7 4855.49 4884.44
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24, 31]. This partitioning helped to resolve the previously 
encountered statistical constraints for detecting genetic 
variation in tolerance of pigs to PRRS in two ways: first, 
it provided repeated measurements of virus load and 
growth to boost the statistical power of the reaction-
norm models covering the entire 42-day infection period, 
and second, it helped to focus the analysis to a stage of 
infection where genetic differences in tolerance are most 
pronounced.
Growth and resistance were heritable across all stages of 
infection, which implies that genetic selection for resist-
ance to PRRS is expected to affect growth and viremia at 
all stages of infection. Estimates of heritability and genetic 
variance for resistance were greatest for VL during the 
highly immune-active time-period between peak viremia 
and maximal rate of viremia clearance [38]. This suggests 
that the phase associated with the most rapid viremia 
decline would be the most affected by genetic selection. 
For growth, heritability was highest at the early stage of 
infection. It is not clear whether this reflects heritable 
genetic differences in growth per se, or already captures 
different growth responses to infection. Genetic correla-
tion between resistance and growth was strongest between 
pre-peak VL and post-peak ADG, which may indicate that 
growth response lags behind and may be affected by ear-
lier viremia response. Other studies on pigs also observed 
that estimates of genetic associations between growth 
and some immune response traits become stronger 
when growth was recorded at a later stage than immune 
response measures, although this also depended on the 
type of immune measure considered [39].
With the univariate single-stage models, significant 
genetic variance in tolerance was only identified when 
late-stage ADG was regressed on mid-stage VL. This 
indicates that genetic variation in tolerance may be sensi-
tive to the timing of measurements. In this case, a unit 
reduction in VL at the rapid phase of post-peak viremia 
decline corresponded to genetic differences in pig growth 
responses at the late-stage of infection, when virus load 
is low. Indeed, where some pigs may be genetically pre-
disposed to experience compensatory growth, other pigs 
may be predisposed to suffer prolonged growth depres-
sion [40].
Adopting a repeated measurements model that 
included viremia and growth measures at the different 
stages of infection, provided further evidence for genetic 
variation in tolerance, as indicated by the considerably 
better model fit of the level-slope model over the level-
only model. According to this model, genetic improve-
ment of one genetic standard deviation in tolerance 
would correspond to a 3.5 g/day difference in growth per 
unit change in VL (Table  5). This means that pigs with 
equal growth rate at mean VL (57.5 units of VL, at which 
the repeated measures model for tolerance was centred), 
but one genetic standard deviation higher tolerance are 
expected to grow 159  g/d faster at the observed maxi-
mum VL of 99.3 VL units. In other words, pigs that have 
low resistance and, therefore, have high VL, would ben-
efit from a genetically higher level of tolerance. It would 
be interesting to know whether such gain in tolerance is 
compromised by lower growth in the absence of infec-
tion. Comparable performance measures of the same pigs 
prior to infection or of non-infected relatives would help 
resolving this question [10].
Associations of the WUR genotype with growth, resistance 
and tolerance
In line with previous analyses of the same data, we found 
a significant and similar effect of genotype at the WUR 
SNP for both VL and ADG, where individuals with the 
favourable AB genotype experienced lower VL and 
higher ADG [24, 26]. As in previous studies, we do not 
report the results with the BB genotype due to the small 
number of individuals (n = 36). Partitioning the infec-
tion period into distinct phases, further revealed that 
the WUR genotype had the strongest effect on VL at 
early- to mid-stages of infection. These results comple-
ment the findings of Boddicker et al. [24], who identified 
a 13.3% reduction in VL between 0 and 21 dpi for indi-
viduals with the favourable AB genotype. Furthermore, 
these results agree with those of Hess et  al. [26] based 
on the same data, who found that the AB genotype was 
associated with lower and earlier peak viremia and faster 
post-peak viremia decline. In contrast, the WUR geno-
type effect on growth was not significant at the early-
stage of infection, but strong (explaining almost 20% of 
the genetic variance in growth) at the stages of post-peak 
viremia decline, highlighting a possible lag effect of WUR 
on growth as a by-product of its stronger association 
with VL at earlier stages. Boddicker et al. [24] previously 
identified a 9.1% increase in growth in individuals with 
the AB genotype. This was identified for the entire period 
of infection (0–42  dpi), which may have reduced the 
genetic signal due to the lag effect of VL on ADG. This 
may explain why a higher increase in growth for individ-
uals with the AB genotype was found in this study (19.4 
and 19.7% for mid- and late-stages of ADG, respectively).
The effect of WUR genotype on tolerance slope was 
not statistically significant at any single stage of infec-
tion, which either indicates lack of statistical power or 
suggests that the association between WUR and ADG at 
mid- to late-stage of infection is a direct consequence of 
the effect of the WUR genotype on resistance. However, 
the repeated measurements model identified a statisti-
cally significant association between WUR genotype and 
overall tolerance slope across all stages of infection, with 
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the beneficial B allele not only conferring greater resist-
ance but also greater tolerance. This indicates that resist-
ance and tolerance, when monitored over a prolonged 
infection period, may share common genetic path-
ways that are partly influenced by the WUR SNP. One 
common pathway may be guanylate binding protein 5 
(GBP5), the putative causative mutation for the observed 
associations of WUR, which was found to be in complete 
linkage disequilibrium with the WUR SNP [41]. GBP5 
is associated with innate immune response to infection, 
where AA animals lack GBP5 functionality [41]. As such, 
it has been hypothesised that reduced viral replication 
(and thus reduced viral load) in AB animals is due to the 
functionality of GBP5. However, the function of GBP5 
with respect to tolerance mechanisms remains unknown. 
Given the association of the WUR SNP with both resist-
ance and tolerance, as identified in this study, it is possi-
ble that GBP5 may also play a role in tolerance.
Benefits arising from partitioning the infection period 
into different stages of infection
One of the novelties of this study compared to previ-
ous analyses of the same dataset was the partitioning of 
the infection period into distinct viremia-profile phases. 
This resulted in two noticeable benefits: first, it provided 
repeated measurements for virus load and growth that 
boosted the statistical power of the random regression 
models, which was key for detecting genetic variation in 
tolerance of pigs to PRRS in this study. Second, partition-
ing the infection period allowed for the possibility that 
genetic mechanisms for resistance and tolerance differ 
over the time course of infection and provided the ability 
to focus on particular stages of infection where genetic 
differences in resistance or tolerance may be most pro-
nounced. Using cumulative viremia over a prolonged 
period of time (e.g. over 21 or 42 days) provides a useful 
summary measure of an individual’s ability to cope with 
infection, but it does not capture the dynamic changes of 
the individual’s viremia curve that could result from the 
action of different immune functions at different stages 
of infection. For example, two individuals may have equal 
VL over the 21-day infection period, but one of the indi-
viduals may experience high viremia over a short time 
followed by rapid clearance, while the other may have 
moderate viremia over a prolonged time [34]. This may 
reflect different immune response patterns and may yield 
a blurred genetic signal when cumulative VL is used as 
phenotype [42]. By defining stages of infection based 
on underlying viremia curve characteristics, the corre-
sponding VL measures may reflect the effect of different 
immune response mechanisms to PRRSV acting over 
time, and thus possibly different sets of genes associated 
with these. For example, the time of fastest rate of viremia 
clearance, which defined the boundary between the mid- 
and late-stage of infection in this study, may coincide 
with the time at which neutralizing antibodies start to 
be produced [43]. Thus, the mid- to late-stages of infec-
tion, for which significant genetic variance in both resist-
ance and tolerance were identified in this study, are likely 
determined by the ability of the individual to mount an 
effective adaptive immune response [44] and how it deals 
with the associated implications on growth [45]. Indeed, 
previous studies found considerable genetic variation in 
total antibody response (measured by serum IgG levels) 
of pigs to PRRSV at 6 weeks post-infection [46, 47].
Partitioning the infection period into distinct phases 
also revealed that genetic parameters for resistance, tol-
erance, and growth changed considerably over the time-
course of infection. For example, the estimate of the 
genetic correlation was strongly positive between mid-
stage ADG and early-stage VL (0.84 + 0.15), indicating 
that genetically resistant individuals with lower VL ear-
lier in infection have slower growth rate in the subse-
quent stage of infection. These results are consistent with 
resource allocation theory, where a temporary trade-off 
between fighting infection and growth may occur due 
to limited nutrient resources being available [45, 48, 49]. 
At the late-stage of infection, the genetic correlation 
between ADG and VL shifted from strongly positive to 
negative (i.e. − 0.74 + 0.21 between late-stage VL and 
late-stage ADG). This period is associated with return to 
homeostasis or even compensatory growth, where ani-
mals that managed to clear the virus faster can allocate 
resources to growth [50]. In summary, these results imply 
that selection for lower VL at the pre-peak viremia phase 
may lead to a reduction in growth during that phase but 
in faster growth at later stages of the infection period, 
and overall. Furthermore, our results suggest that genetic 
selection to increase tolerance would be effective only in 
the phase of rapid viremia decline.
Sensitivity of tolerance estimates to the partitioning 
of the infection period
In this study, stages of infection were defined with the 
help of the mathematical Woods function, which allowed 
partitioning into distinct infection phases based on 
viremia profile characteristics, i.e. the phase associated 
with viremia increase towards peak viremia, the phase 
of rapid post-peak decline, and the later phase corre-
sponding to more gradual viremia decline. The question 
arises on how sensitive the results are to the definition of 
infection stages according to the Woods function. Pre-
vious analyses of the viremia data from trials 1 to 8 had 
fitted a LOESS curve through the data and integrated to 
obtain area under the curve from 0 to 21 dpi [26, 34]. A 
subsequent study demonstrated similar heritabilities and 
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high genetic and phenotypic correlations between viral 
loads established by both methods, and concluded that 
both methods describe the same biological trait [34]. 
Furthermore, the analyses of this study were repeated 
for an alternative definition of stages of infection, in 
which they were simply defined according to the fol-
lowing three fixed time-periods: from 0 to 7 dpi (early), 
from 7 to 14 dpi (mid) and from 14 to 42 dpi (late). As 
shown in Additional file  2, the fixed time-periods pro-
vided similar evidence for genetic variation in tolerance: 
the repeated measurement model identified significant 
genetic variation in tolerance to infection and the single 
measurement models applied to VL and ADG at differ-
ent stages of infection identified genetic variance in toler-
ance only for the late-stage of infection (although in this 
case when late-stage ADG was regressed on late-stage 
VL, rather than on mid-stage VL, as was the case when 
stages of infection were defined based on viremia char-
acteristics). These results indicate that specification of 
infection stages according to individual profile charac-
teristics is not essential for detecting genetic variation in 
tolerance. Nevertheless, time-periods that are based on 
individual infection profiles rather than on fixed meas-
urement times would be expected to better reflect the 
dynamic behaviour of genetic resistance and tolerance 
mechanisms, as indicated by generally higher heritability 
estimates for VL and ADG (see Additional file 2). Finally, 
it should be mentioned that partitioning data into dis-
tinct stages of infection has proven useful, but may not 
harness the full information about how resistance and 
tolerance mechanisms interact over time that is captured 
by the longitudinal viremia and growth data. Such infor-
mation may be better portrayed through individual infec-
tion trajectories [11, 12, 51], although the methodology 
for genetic trajectory analyses is still in its infancy.
Implications for breeding programmes and conclusions
The results of this study suggest that, in principle, genetic 
selection for greater tolerance of pigs to PRRS is possi-
ble and may indeed result in an increase in growth rate 
of pigs infected with PRRSV. However, in practical terms 
tolerance may be difficult to target for genetic selection, 
given that multiple repeated measures may be needed 
for each individual, and information of performance 
and within-host–pathogen load are needed for multi-
ple offspring of each sire. This high demand in data for 
estimating tolerance suggests that genetic improvement 
of tolerance of pigs to PRRSV can only be achieved real-
istically with genomic selection and intense recording 
schemes that involve repeated measurements to reli-
ably estimate genetic effects [52]. Furthermore, incor-
poration of tolerance into breeding programmes would 
require understanding the genetic correlations between 
resistance and tolerance, and how these both contribute 
to overall resilience of pigs exposed to PRRSV [15]. Note 
that we were not able to estimate genetic correlations 
between resistance and tolerance to PRRS in this study 
because VL was used both as a measure of resistance (i.e. 
response variable) and as predictor for tolerance in the 
random regression models. This sequential interdepend-
ence calls for more sophisticated methods such as struc-
tural equation models to estimate the true relationships 
between these traits [53, 54].
Perhaps the most relevant result of this study regarding 
practical pig breeding was that the genotype at the WUR 
SNP was found to be significantly associated with resist-
ance, growth and tolerance, with the favourable B allele 
likely improving all three traits. This suggests that resist-
ance and tolerance are partly pleiotropic and thus work 
together to improve host performance, and that selection 
for greater resistance may simultaneously improve toler-
ance, and consequently also growth of piglets infected 
with PRRSV. Based on the results of this study, consider-
ation of the WUR genotype in genetic selection schemes 
appears to be a promising strategy to improve simultane-
ously resistance and tolerance of growing pigs to PRRS in 
the absence of intense data recording.
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